Geert Cauwenbergh
Legacy Healthcare, Route de la Corniche 9B, 1066 Epalinges, Switzerland
Dr. Cauwenbergh served as our President and Chief Executive Officer from April 2012 until his retirement in March 2019. Prior to joining Phio, Dr. Cauwenbergh served as Chairman and Chief Executive Officer of Barrier Therapeutics, Inc., a publicly-traded biopharmaceutical company he founded in 2001 that focused on dermatology drug development. Barrier was acquired by Stiefel Laboratories, Inc. in 2008. Prior to founding Barrier, Dr. Cauwenbergh held a number of ascending senior management positions at Johnson & Johnson, where he was employed for 23 years.
